Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial
- REPLACE investigators
研究成果: Article › 同行評審
143
!!Link opens in a new tab
引文
斯高帕斯（Scopus）